Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - Total assets
Total assets on the balance sheet as of December 2023 : $3.9 M
According to Yield10 Bioscience's latest financial reports the company's total assets are $3.9 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Yield10 Bioscience - Total assets on balance sheet (from 2004 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $8.08 M | -60.4% |
| 2021-12-31 | $20.41 M | 40.58% |
| 2020-12-31 | $14.52 M | -13.14% |
| 2019-12-31 | $16.71 M | 29% |
| 2018-12-31 | $12.96 M | -23.23% |
| 2017-12-31 | $16.88 M | 57.07% |
| 2016-12-31 | $10.74 M | -37.1% |
| 2015-12-31 | $17.08 M | -26.14% |
| 2014-12-31 | $23.13 M | -13.48% |
| 2013-12-31 | $26.73 M | -50.03% |
| 2012-12-31 | $53.51 M | -35.46% |
| 2011-12-31 | $82.91 M | 24.17% |
| 2010-12-31 | $66.77 M | -31.55% |
| 2009-12-31 | $97.55 M | 0.63% |
| 2008-12-31 | $96.94 M | -18.54% |
| 2007-12-31 | $0.11 B | -6.73% |
| 2006-12-31 | $0.12 B | 1641.92% |
| 2005-12-31 | $7.32 M | -2.46% |
| 2004-12-31 | $7.5 M | |
| 2002-12-31 | $2.56 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.27 M | -93.06% | Bahamas |
 NRC Health
NRC | $0.12 B | 3,033.79% | 🇺🇸 USA |